• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定 Huh-7 细胞中的离子型嘌呤能受体及其对 HCV 3a 基因型结构蛋白的反应。

Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a.

机构信息

National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.

出版信息

Virol J. 2011 Sep 8;8:431. doi: 10.1186/1743-422X-8-431.

DOI:10.1186/1743-422X-8-431
PMID:21899776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3177911/
Abstract

Hepatitis C virus (HCV) is a major health problem in developing countries including Pakistan. Chronic HCV infection results in progressive liver disease including fibrosis, cirrhosis, insulin resistance and eventually hepatocellular carcinoma (HCC). Ionotrophic purinergic (P2X) receptors are identified to involve in a spectrum of physiological and pathophysiological processes. However, the role of P2X receptors in HCV liver associated diseases still remains to be investigated. The current study was designed to identify the presence of P2X receptors in human liver cells. Furthermore, it investigates the response of P2X receptors towards HCV structural proteins (E1E2). To determine that how many isoforms of P2X receptors are expressed in human liver cells, human hepatoma cell line (Huh-7) was used. Transcripts (mRNA) of five different isoforms of P2X receptors were identified in Huh-7 cells. To examine the gene expression of identified isoforms of P2X receptors in presence of HCV structural proteins E1E2, Huh-7/E1E2 cell line (stably expressing HCV structural proteins E1E2) was used. The results showed significant increase (6.2 fold) in gene expression of P2X4 receptors in Huh-7/E1E2 cells as compared to control Huh-7 cells. The findings of present study confirmed the presence of transcripts of five different isoforms of P2X receptors in human liver cells and suggest that P2X4 receptors could be represented an important component of the purinergic signaling complex in HCV induced liver pathogenesis.

摘要

丙型肝炎病毒 (HCV) 是包括巴基斯坦在内的发展中国家的一个主要健康问题。慢性 HCV 感染会导致进行性肝脏疾病,包括纤维化、肝硬化、胰岛素抵抗,最终导致肝细胞癌 (HCC)。离子型嘌呤能 (P2X) 受体被确定参与一系列生理和病理生理过程。然而,P2X 受体在 HCV 相关肝病中的作用仍有待研究。本研究旨在确定 P2X 受体在人肝细胞中的存在。此外,它还研究了 P2X 受体对 HCV 结构蛋白 (E1E2) 的反应。为了确定 P2X 受体在人肝细胞中表达的亚型有多少,使用了人肝癌细胞系 (Huh-7)。在 Huh-7 细胞中鉴定出五种不同亚型的 P2X 受体的转录本 (mRNA)。为了研究在 HCV 结构蛋白 E1E2 存在下鉴定出的 P2X 受体亚型的基因表达,使用了 Huh-7/E1E2 细胞系(稳定表达 HCV 结构蛋白 E1E2)。结果显示,与对照 Huh-7 细胞相比,Huh-7/E1E2 细胞中 P2X4 受体的基因表达显著增加 (6.2 倍)。本研究的结果证实了人肝细胞中存在五种不同亚型的 P2X 受体的转录本,并表明 P2X4 受体可能是 HCV 诱导的肝发病机制中嘌呤能信号复合物的重要组成部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/3177911/c5c99ec8cce9/1743-422X-8-431-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/3177911/4214e2c4909f/1743-422X-8-431-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/3177911/c5c99ec8cce9/1743-422X-8-431-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/3177911/4214e2c4909f/1743-422X-8-431-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd5/3177911/c5c99ec8cce9/1743-422X-8-431-2.jpg

相似文献

1
Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a.鉴定 Huh-7 细胞中的离子型嘌呤能受体及其对 HCV 3a 基因型结构蛋白的反应。
Virol J. 2011 Sep 8;8:431. doi: 10.1186/1743-422X-8-431.
2
Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor.嘌呤受体在丙型肝炎病毒(HCV)诱导的和非HCV肝细胞癌中的表达:深入了解P2X4受体的前病毒作用。
Mol Biol Rep. 2018 Dec;45(6):2625-2630. doi: 10.1007/s11033-018-4432-0. Epub 2018 Oct 20.
3
Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection.丙型肝炎病毒感染中的线粒体损伤和铁代谢失调。
Free Radic Biol Med. 2019 Mar;133:193-199. doi: 10.1016/j.freeradbiomed.2018.09.044. Epub 2018 Sep 27.
4
P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis.P2X4 受体介导抗氧化剂、纤维生成细胞因子和 ECM 转录物的诱导;在体外存在复制的 HCV 的情况下:对 P2X4 在纤维化中的作用的深入了解。
PLoS One. 2022 May 20;17(5):e0259727. doi: 10.1371/journal.pone.0259727. eCollection 2022.
5
Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.白细胞介素-32:一种新型促炎细胞因子,参与丙型肝炎病毒相关肝炎症和纤维化。
Hepatology. 2011 Jun;53(6):1819-29. doi: 10.1002/hep.24285. Epub 2011 May 14.
6
Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.丙型肝炎肝硬化中促增殖基因以及配体/受体对胎盘生长因子和血管内皮生长因子受体1的上调。
Liver Int. 2007 Sep;27(7):960-8. doi: 10.1111/j.1478-3231.2007.01542.x.
7
Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.丙型肝炎病毒相关慢性肝病中的Smad3磷酸化异构体信号传导
World J Gastroenterol. 2014 Sep 21;20(35):12381-90. doi: 10.3748/wjg.v20.i35.12381.
8
Modulation of Cell Death Pathways by Hepatitis C Virus Proteins in Huh7.5 Hepatoma Cells.丙型肝炎病毒蛋白对 Huh7.5 肝癌细胞细胞死亡途径的调控。
Int J Mol Sci. 2017 Nov 6;18(11):2346. doi: 10.3390/ijms18112346.
9
Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.在细胞培养和鼠肿瘤异种移植中丙型肝炎病毒诱导的癌症干细胞样特征。
J Virol. 2011 Dec;85(23):12292-303. doi: 10.1128/JVI.05920-11. Epub 2011 Sep 21.
10
Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages.丙型肝炎病毒诱导循环和驻留于肝脏的巨噬细胞中白细胞介素-1β(IL-1β)/白细胞介素-18。
J Virol. 2013 Nov;87(22):12284-90. doi: 10.1128/JVI.01962-13. Epub 2013 Sep 4.

引用本文的文献

1
The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage.P2X7R-NLRP3 和 AIM2 炎性小体平台标志着病毒或代谢性肝损伤的复杂性/严重程度。
Int J Mol Sci. 2022 Jul 4;23(13):7447. doi: 10.3390/ijms23137447.
2
The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.嘌呤能信号在抗包括 SARS-CoV-2 在内的病毒方面的潜力。
Front Immunol. 2022 Jun 17;13:904419. doi: 10.3389/fimmu.2022.904419. eCollection 2022.
3
P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis.

本文引用的文献

1
High baseline interleukine-8 level is an independent risk factor for the achievement of sustained virological response in chronic HCV patients.基线白细胞介素-8 水平高是慢性 HCV 患者获得持续病毒学应答的独立危险因素。
Infect Genet Evol. 2011 Aug;11(6):1301-5. doi: 10.1016/j.meegid.2011.04.021. Epub 2011 Apr 28.
2
Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis.基因型 1a 和 3a 的 HCV 核心基因与宿主基因 Cox-2 在 HCV 诱导发病机制中的作用。
Virol J. 2011 Apr 1;8:155. doi: 10.1186/1743-422X-8-155.
3
Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.
P2X4 受体介导抗氧化剂、纤维生成细胞因子和 ECM 转录物的诱导;在体外存在复制的 HCV 的情况下:对 P2X4 在纤维化中的作用的深入了解。
PLoS One. 2022 May 20;17(5):e0259727. doi: 10.1371/journal.pone.0259727. eCollection 2022.
4
Pathophysiological Role of Purinergic P2X Receptors in Digestive System Diseases.嘌呤能P2X受体在消化系统疾病中的病理生理作用
Front Physiol. 2021 Dec 24;12:781069. doi: 10.3389/fphys.2021.781069. eCollection 2021.
5
Purinergic Signaling in Liver Pathophysiology.嘌呤能信号在肝脏病理生理学中的作用。
Front Endocrinol (Lausanne). 2021 Aug 11;12:718429. doi: 10.3389/fendo.2021.718429. eCollection 2021.
6
The Pannexin 1/Purinergic Receptor P2X4 Pathway Controls the Secretion of MicroRNA-Containing Exosomes by HCV-Infected Hepatocytes.Pannexin 1/嘌呤能受体 P2X4 通路通过 HCV 感染的肝细胞控制含 microRNA 的外泌体的分泌。
Hepatology. 2021 Dec;74(6):3409-3426. doi: 10.1002/hep.32042. Epub 2021 Aug 30.
7
Autocrine and paracrine purinergic signaling in the most lethal types of cancer.自分泌和旁分泌嘌呤能信号在最致命类型的癌症中的作用。
Purinergic Signal. 2021 Sep;17(3):345-370. doi: 10.1007/s11302-021-09785-8. Epub 2021 May 12.
8
Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities.肝脏疾病中的嘌呤能信号传导:病理功能与治疗机遇
JHEP Rep. 2020 Jul 30;2(6):100165. doi: 10.1016/j.jhepr.2020.100165. eCollection 2020 Dec.
9
Purinergic Receptors: Elucidating the Role of these Immune Mediators in HIV-1 Fusion.嘌呤能受体:阐明这些免疫介质在 HIV-1 融合中的作用。
Viruses. 2020 Mar 7;12(3):290. doi: 10.3390/v12030290.
10
P2Y2 purinergic receptor modulates virus yield, calcium homeostasis, and cell motility in human cytomegalovirus-infected cells.P2Y2 嘌呤能受体调节人巨细胞病毒感染细胞中的病毒产量、钙稳态和细胞迁移。
Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):18971-18982. doi: 10.1073/pnas.1907562116. Epub 2019 Sep 3.
使用合成和载体衍生的 siRNA 抑制 HCV 3a 基因型的核心基因。
Virol J. 2010 Nov 13;7:318. doi: 10.1186/1743-422X-7-318.
4
HCV genotype distribution and possible transmission risks in Lahore, Pakistan.巴基斯坦拉合尔市丙型肝炎病毒基因型分布及可能的传播风险。
World J Gastroenterol. 2010 Sep 14;16(34):4321-8. doi: 10.3748/wjg.v16.i34.4321.
5
Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience.丙型肝炎病毒基因型 3a 感染与肝细胞癌:巴基斯坦的经验。
World J Gastroenterol. 2009 Oct 28;15(40):5080-5. doi: 10.3748/wjg.15.5080.
6
Cellular and molecular biology of HCV infection and hepatitis.丙型肝炎病毒感染与肝炎的细胞和分子生物学
Clin Sci (Lond). 2009 Jun 15;117(2):49-65. doi: 10.1042/CS20080631.
7
Regulation of cellular ATP release.细胞ATP释放的调节
Trans Am Clin Climatol Assoc. 2007;118:199-208.
8
Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission.巴基斯坦不同地理区域丙型肝炎病毒基因型的频率分布及其可能的传播途径。
BMC Infect Dis. 2008 May 23;8:69. doi: 10.1186/1471-2334-8-69.
9
Hepatitis C virus infection: molecular pathways to metabolic syndrome.丙型肝炎病毒感染:通往代谢综合征的分子途径。
Hepatology. 2008 Jun;47(6):2127-33. doi: 10.1002/hep.22269.
10
Characterization of ionotrophic purinergic receptors in hepatocytes.肝细胞中离子型嘌呤能受体的特征分析。
Hepatology. 2008 Feb;47(2):698-705. doi: 10.1002/hep.22035.